34 related articles for article (PubMed ID: 15812397)
1. Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil.
Sakatoku K; Kim SW; Okamura H; Kanaya M; Kato K; Yamasaki S; Uchida N; Kobayashi H; Fukuda T; Takayama N; Ishikawa J; Nakazawa H; Sakurai M; Ikeda T; Kondo T; Yoshioka S; Miyamoto T; Kimura T; Ichinohe T; Atsuta Y; Kondo E
Ann Hematol; 2022 Dec; 101(12):2743-2757. PubMed ID: 36195679
[TBL] [Abstract][Full Text] [Related]
2. Successful myeloablative unrelated bone marrow transplantation for relapsed intravascular large B cell lymphoma after autologous peripheral blood stem cell transplantation.
Miura Y; Ooi J; Matsuo T; Yamamoto T; Sumiyoshi R; Saito S; Matsumoto K; Tashiro H; Shirafuji N
Ann Hematol; 2021 Dec; 100(12):3067-3069. PubMed ID: 33090263
[No Abstract] [Full Text] [Related]
3. Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery.
Mehta RS; Saliba RM; Cao K; Kaur I; Rezvani K; Chen J; Olson A; Parmar S; Shah N; Marin D; Alousi A; Hosing C; Popat U; Kebriaei P; Champlin R; de Lima M; Skerrett D; Burke E; Shpall EJ; Oran B
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1359-1366. PubMed ID: 28506845
[TBL] [Abstract][Full Text] [Related]
4. Reduced-intensity allogeneic stem cell transplantation for co-emergence of chemotherapy-refractory follicular lymphoma and therapy-related myelodysplastic syndrome.
Shimura Y; Kuroda J; Sasaki N; Uchiyama H; Ohshiro M; Matsumura Y; Nagoshi H; Mizutani S; Kobayashi T; Matsumoto Y; Horiike S; Taniwaki M
Case Rep Oncol; 2014 Jan; 7(1):188-94. PubMed ID: 24748869
[TBL] [Abstract][Full Text] [Related]
5. A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Bone Marrow Transplant; 2014 Jul; 49(7):955-60. PubMed ID: 24732960
[TBL] [Abstract][Full Text] [Related]
6. Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood.
Rodrigues CA; Rocha V; Dreger P; Brunstein C; Sengeloev H; Finke J; Mohty M; Rio B; Petersen E; Guilhot F; Niederwieser D; Cornelissen JJ; Jindra P; Nagler A; Fegueux N; Schoemans H; Robinson S; Ruggeri A; Gluckman E; Canals C; Sureda A; ;
Haematologica; 2014 Feb; 99(2):370-7. PubMed ID: 23935024
[TBL] [Abstract][Full Text] [Related]
7. Fifty years of melphalan use in hematopoietic stem cell transplantation.
Bayraktar UD; Bashir Q; Qazilbash M; Champlin RE; Ciurea SO
Biol Blood Marrow Transplant; 2013 Mar; 19(3):344-56. PubMed ID: 22922522
[TBL] [Abstract][Full Text] [Related]
8. A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients.
Geyer MB; Jacobson JS; Freedman J; George D; Moore V; van de Ven C; Satwani P; Bhatia M; Garvin JH; Bradley MB; Harrison L; Morris E; Della-Latta P; Schwartz J; Baxter-Lowe LA; Cairo MS
Br J Haematol; 2011 Oct; 155(2):218-34. PubMed ID: 21848882
[TBL] [Abstract][Full Text] [Related]
9. Unrelated umbilical cord blood transplantation and immune reconstitution.
Szabolcs P; Cairo MS
Semin Hematol; 2010 Jan; 47(1):22-36. PubMed ID: 20109609
[TBL] [Abstract][Full Text] [Related]
10. Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood.
Smith AR; Wagner JE
Br J Haematol; 2009 Oct; 147(2):246-61. PubMed ID: 19796274
[TBL] [Abstract][Full Text] [Related]
11. Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation.
Brunstein CG; Cantero S; Cao Q; Majhail N; McClune B; Burns LJ; Tomblyn M; Miller JS; Blazar BR; McGlave PB; Weisdorf DJ; Wagner JE
Biol Blood Marrow Transplant; 2009 Feb; 15(2):214-22. PubMed ID: 19167681
[TBL] [Abstract][Full Text] [Related]
12. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.
Brunstein CG; Barker JN; Weisdorf DJ; DeFor TE; Miller JS; Blazar BR; McGlave PB; Wagner JE
Blood; 2007 Oct; 110(8):3064-70. PubMed ID: 17569820
[TBL] [Abstract][Full Text] [Related]
13. Double unrelated reduced-intensity umbilical cord blood transplantation in adults.
Ballen KK; Spitzer TR; Yeap BY; McAfee S; Dey BR; Attar E; Haspel R; Kao G; Liney D; Alyea E; Lee S; Cutler C; Ho V; Soiffer R; Antin JH
Biol Blood Marrow Transplant; 2007 Jan; 13(1):82-9. PubMed ID: 17222756
[TBL] [Abstract][Full Text] [Related]
14. Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow.
Misawa M; Kai S; Okada M; Nakajima T; Nomura K; Wakae T; Toda A; Itoi H; Takatsuka H; Itsukuma T; Nishioka K; Fujimori Y; Ogawa H; Hara H
Int J Hematol; 2006 Jan; 83(1):74-9. PubMed ID: 16443557
[TBL] [Abstract][Full Text] [Related]
15. Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma.
Yuji K; Miyakoshi S; Kato D; Miura Y; Myojo T; Murashige N; Kishi Y; Kobayashi K; Kusumi E; Narimatsu H; Hamaki T; Matsumura T; Kami M; Fukuda T; Masuo S; Masuoka K; Wake A; Ueyama J; Yoneyama A; Miyamoto K; Nagoshi H; Matsuzaki M; Morinaga S; Muto Y; Takeue Y; Taniguchi S;
Biol Blood Marrow Transplant; 2005 Apr; 11(4):314-8. PubMed ID: 15812397
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases.
Miyakoshi S; Kami M; Tanimoto T; Yamaguchi T; Narimatsu H; Kusumi E; Matsumura T; Takagi S; Kato D; Kishi Y; Murashige N; Yuji K; Uchida N; Masuoka K; Wake A; Taniguchi S
Transplantation; 2007 Aug; 84(3):316-22. PubMed ID: 17700155
[TBL] [Abstract][Full Text] [Related]
17. Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases.
Miyakoshi S; Yuji K; Kami M; Kusumi E; Kishi Y; Kobayashi K; Murashige N; Hamaki T; Kim SW; Ueyama J; Mori S; Morinaga S; Muto Y; Masuo S; Kanemaru M; Hayashi T; Takaue Y; Taniguchi S
Clin Cancer Res; 2004 Jun; 10(11):3586-92. PubMed ID: 15173064
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies.
Mori T; Aisa Y; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Yamane A; Ikeda Y; Okamoto S
Transplant Proc; 2007 Jun; 39(5):1615-9. PubMed ID: 17580201
[TBL] [Abstract][Full Text] [Related]
19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
